Personalized neoantigen cancer vaccines
Neoantigen cancer vaccines
Questions about virotherapy?
Contact us for a non-binding consultation.
A new generation of precision immunotherapy
Personalized neoantigen cancer vaccines are among the most innovative developments in modern cancer medicine. This form of personalized cancer immunotherapy uses the genetic characteristics of a tumour to specifically activate the immune system against cancer cells.
With the progress of precision medicine in oncology, it is becoming increasingly possible to tailor treatments to the genetic profile of a tumor. Neoantigen vaccines are an important part of this development.
What are neoantigens?
Neoantigens are protein structures that are produced by genetic mutations in cancer cells. These proteins are found exclusively on tumor cells and not on healthy body cells.
This enables the immune system to recognize these structures as foreign and react to them in a targeted manner. It is precisely this property that makes neoantigens ideal target structures for modern immunotherapies against cancer.
The discovery of these tumour-specific antigens has paved the way for personalized cancer vaccines.
How do personalized cancer vaccines work?
The development of a personalized neoantigen vaccine takes place in several steps.
Genetic analysis of the tumor
First, a comprehensive genomic sequencing of the tumor tissue is performed.
Identification of the neoantigens
The genetic changes are used to identify the individual neoantigens of the tumor.
Development of a customized vaccine
A customized cancer vaccine is developed on the basis of this information.
Activation of the immune system
The vaccine trains the immune system to:
- specifically recognize tumour cells
- activate immune cells such as T cells
- specifically fight cancer cells
As this therapy specifically targets tumour mutations, healthy tissue can be largely spared.
Potential benefits of personalized neoantigen vaccines
Personalized cancer vaccines offer several potential benefits:
- Targeted immune response against tumor cells
- Individually tailored therapy based on tumor genetics
- Possibility of combination with immunotherapies such as checkpoint inhibitors
- Potentially less stress for healthy tissue
This form of therapy is an important component of modern precision oncology.
Clinical research and future prospects
Personalized neoantigen cancer vaccines are currently being investigated in numerous clinical trials worldwide.
Initial studies show promising results in various types of cancer, including:
- Melanoma
- Lung cancer
- Colorectal cancer
- Pancreatic cancer
The combination of these vaccines with checkpoint inhibitors to further strengthen the immune response against tumors is particularly promising.
With advances in genome research and immunology, personalized cancer vaccines could play an increasingly important role in cancer treatment in the future.
Precision medicine in oncology
The development of neoantigen vaccines is exemplary for the change in cancer medicine: away from standardized therapies towards individual, biologically precisely coordinated treatments.
This form of personalized cancer medicine opens up new possibilities for the targeted and innovative treatment of tumor diseases.
Free advice on the neoantigen cancer vaccine
Our specialized team will be happy to answer your questions about the Neoantigen cancer vaccine and create an individual treatment plan for you.